{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:02:39Z","timestamp":1778958159856,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004305","name":"Shahroud University of Medical Sciences","doi-asserted-by":"crossref","award":["99135 and 140068"],"award-info":[{"award-number":["99135 and 140068"]}],"id":[{"id":"10.13039\/501100004305","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"crossref","award":["2021\/1169483-0 and,2022\/1217943-1"],"award-info":[{"award-number":["2021\/1169483-0 and,2022\/1217943-1"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003969","name":"Iranian Ministry of Health and Medical Education","doi-asserted-by":"crossref","award":["2302"],"award-info":[{"award-number":["2302"]}],"id":[{"id":"10.13039\/501100003969","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03015-2","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T07:58:40Z","timestamp":1755503920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adverse events of special interest after vaccination with COVID-19 vaccines: a cohort event monitoring study in Iran"],"prefix":"10.1186","volume":"30","author":[{"given":"Roqayeh","family":"Aliyari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hassan","family":"Emamian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Enayatrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajad","family":"Sahab-Negah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sairan","family":"Nili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Fereidouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parvin","family":"Mangolian shahrbabaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Ansari-Moghadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariba","family":"Shahraki-Sanavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansooreh","family":"Fateh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Khajeha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Emamian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elahe","family":"Behmanesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"3015_CR1","unstructured":"World Health Organization. COVID-19 epidemiological update \u2013 12 March 2024. 2025 https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update-edition-177."},{"key":"3015_CR2","unstructured":"World Health Organization. COVID-19 vaccine tracker and landscape 2023 [Available from: https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines."},{"key":"3015_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2024.100485","volume":"18","author":"PA ShamaeiZadeh","year":"2024","unstructured":"ShamaeiZadeh PA, Jaimes CV, Knoll MD, Espi\u00e9 E, Chandler RE. Landscape review of active vaccine safety surveillance activities for COVID-19 vaccines globally. Vaccine X. 2024;18: 100485.","journal-title":"Vaccine X"},{"issue":"1","key":"3015_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0296669","volume":"19","author":"M Eterafi","year":"2024","unstructured":"Eterafi M, Fouladi N, Golizadeh M, Shaker H, Matin S, Safarzadeh E. Reported side-effects following Oxford\/AstraZeneca COVID-19 vaccine in the north-west province, Iran: a cross-sectional study. PLoS ONE. 2024;19(1): e0296669.","journal-title":"PLoS ONE"},{"issue":"1","key":"3015_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00963-7","volume":"11","author":"F Babamahmoodi","year":"2021","unstructured":"Babamahmoodi F, Saeedi M, Alizadeh-Navaei R, Hedayatizadeh-Omran A, Mousavi SA, Ovaise G, et al. Side effects and immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran. Sci Rep. 2021;11(1): 21464.","journal-title":"Sci Rep"},{"issue":"1","key":"3015_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7774\/cevr.2023.12.1.25","volume":"12","author":"R Jafarzadeh Esfehani","year":"2023","unstructured":"Jafarzadeh Esfehani R, Zahmatkesh M, Goldozian R, Farkhonde J, Jaripour E, Hatami A, et al. Adverse events following immunisation with the first dose of Sputnik V among Iranian health care providers. Clin Exp Vaccine Res. 2023;12(1):25\u201331.","journal-title":"Clin Exp Vaccine Res"},{"key":"3015_CR7","first-page":"99","volume":"37","author":"M Zare","year":"2023","unstructured":"Zare M, Mirahmadizadeh A, Khosravi M, Karimi M, Dehghani SL. Comparison of time to report the side effects after AstraZeneca and Sinopharm vaccinations in users of the COVID-19 symptom study app: a survey in South Iran. Med J Islam Repub Iran. 2023;37:99.","journal-title":"Med J Islam Repub Iran"},{"issue":"1","key":"3015_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12879-022-07411-5","volume":"22","author":"E Babaee","year":"2022","unstructured":"Babaee E, Amirkafi A, Tehrani-Banihashemi A, SoleimanvandiAzar N, Eshrati B, Rampisheh Z, et al. Adverse effects following COVID-19 vaccination in Iran. BMC Infect Dis. 2022;22(1):476.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"3015_CR9","doi-asserted-by":"publisher","first-page":"e486","DOI":"10.5001\/omj.2023.69","volume":"38","author":"A Abdollahi","year":"2023","unstructured":"Abdollahi A, Naseh I, Kalroozi F, Kazemi-Galougahi MH, Nezamzadeh M, Qorbanzadeh A, et al. Potential adverse effects of COVID-19 vaccines on Iranian healthcare workers: comparison of four available vaccines in Tehran: a retrospective cross-sectional study. Oman Med J. 2023;38(2):e486.","journal-title":"Oman Med J"},{"issue":"2","key":"3015_CR10","first-page":"189","volume":"15","author":"D Yadegarynia","year":"2023","unstructured":"Yadegarynia D, Tehrani S, Hadavand F, Arshi S, Abtahian Z, Keyvanfar A, et al. Side effects after COVID-19 vaccination: a comparison between the most common available vaccines in Iran. Iran J Microbiol. 2023;15(2):189\u201395.","journal-title":"Iran J Microbiol"},{"key":"3015_CR11","unstructured":"World Health Organization. Protocol template to be used as template for observational study protocols: cohort event monitoring (CEM) for safety signal detection after vaccination with COVID-19 vaccines 2021 [Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/342193."},{"issue":"1","key":"3015_CR12","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1186\/s12889-022-13575-1","volume":"22","author":"R Aliyari","year":"2022","unstructured":"Aliyari R, Mahdavi S, Enayatrad M, Sahab-Negah S, Nili S, Fereidooni M, et al. Study protocol: cohort event monitoring for safety signal detection after vaccination with COVID-19 vaccines in Iran. BMC Public Health. 2022;22(1):1153.","journal-title":"BMC Public Health"},{"issue":"8","key":"3015_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2471\/BLT.22.288073","volume":"100","author":"A Hosseinzadeh","year":"2022","unstructured":"Hosseinzadeh A, Sahab-Negah S, Nili S, Aliyari R, Goli S, Fereidouni M, et al. COVID-19 cases, hospitalizations and deaths after vaccination: a cohort event monitoring study, Islamic Republic of Iran. Bull World Health Organ. 2022;100(8):474\u201383.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"3015_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12879-023-08103-4","volume":"23","author":"M Enayatrad","year":"2023","unstructured":"Enayatrad M, Mahdavi S, Aliyari R, Sahab-Negah S, Nili S, Fereidouni M, et al. Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system. BMC Infect Dis. 2023;23(1):150.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"3015_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s40264-023-01281-9","volume":"46","author":"M Raethke","year":"2023","unstructured":"Raethke M, van Hunsel F, Thurin NH, Dureau-Pournin C, Mentzer D, Kova\u010di\u0107 B, et al. Cohort event monitoring of adverse reactions to COVID-19 vaccines in seven European countries: pooled results on first dose. Drug Saf. 2023;46(4):391\u2013404.","journal-title":"Drug Saf"},{"key":"3015_CR16","unstructured":"Luxi N, Riefolo F, Raethke M, van Hunsel F, Sturkenboom M, Trifir\u00f2 G. Covid-Vaccine-Monitor - Final Study Report for Cohort Event Monitoring (WP1, WP2, WP5). 2023."},{"issue":"6","key":"3015_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004018","volume":"19","author":"CKH Wong","year":"2022","unstructured":"Wong CKH, Lau KTK, Xiong X, Au ICH, Lai FTT, Wan EYF, et al. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: a retrospective study. PLoS Med. 2022;19(6): e1004018.","journal-title":"PLoS Med"},{"issue":"6","key":"3015_CR18","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s40264-023-01301-8","volume":"46","author":"U Kaur","year":"2023","unstructured":"Kaur U, Fatima Z, Maheshwari K, Sahni V, Dehade A, Kl A, et al. Long-term safety analysis of the ChAdOx1-nCoV-19 corona virus vaccine: results from a prospective observational study in priority vaccinated groups in North India. Drug Saf. 2023;46(6):553\u201363.","journal-title":"Drug Saf"},{"issue":"42","key":"3015_CR19","doi-asserted-by":"publisher","first-page":"6227","DOI":"10.1016\/j.vaccine.2023.08.079","volume":"41","author":"A Phillips","year":"2023","unstructured":"Phillips A, Jiang Y, Walsh D, Andrews N, Artama M, Clothier H, et al. Background rates of adverse events of special interest for COVID-19 vaccines: a multinational Global Vaccine Data Network (GVDN) analysis. Vaccine. 2023;41(42):6227\u201338.","journal-title":"Vaccine"},{"issue":"2","key":"3015_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.vaccine.2022.11.003","volume":"41","author":"K Moll","year":"2023","unstructured":"Moll K, Lufkin B, Fingar KR, Ke Zhou C, Tworkoski E, Shi C, et al. Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019\u20132020. Vaccine. 2023;41(2):333\u201353.","journal-title":"Vaccine"},{"issue":"10","key":"3015_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s40261-022-01191-1","volume":"42","author":"DH Abdel-Qader","year":"2022","unstructured":"Abdel-Qader DH, Abdel-Qader H, Silverthorne J, Kongkaew C, Al Meslamani AZ, Hayajneh W, et al. Active safety surveillance of four types of COVID-19 vaccines: a national study from Jordan. Clin Drug Investig. 2022;42(10):813\u201327.","journal-title":"Clin Drug Investig"},{"issue":"9","key":"3015_CR22","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","volume":"42","author":"K Faksova","year":"2024","unstructured":"Faksova K, Walsh D, Jiang Y, Griffin J, Phillips A, Gentile A, et al. COVID-19 vaccines and adverse events of special interest: a multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine. 2024;42(9):2200\u201311.","journal-title":"Vaccine"},{"issue":"7","key":"3015_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s40261-022-01164-4","volume":"42","author":"M Atzenhoffer","year":"2022","unstructured":"Atzenhoffer M, Auffret M, Pegat A, Masmoudi K, Khouri C, Bertin B, et al. Guillain-barr\u00e9 syndrome associated with COVID-19 vaccines: a perspective from spontaneous report data. Clin Drug Investig. 2022;42(7):581\u201392.","journal-title":"Clin Drug Investig"},{"issue":"4","key":"3015_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.8879","volume":"5","author":"KE Hanson","year":"2022","unstructured":"Hanson KE, Goddard K, Lewis N, Fireman B, Myers TR, Bakshi N, et al. Incidence of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the vaccine safety datalink. JAMA Netw Open. 2022;5(4): e228879.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"3015_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/14740338.2022.2120607","volume":"22","author":"M Otero-Losada","year":"2023","unstructured":"Otero-Losada M, Petrovsky N, Alami A, Crispo JA, Mattison D, Capani F, et al. Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom. Expert Opin Drug Saf. 2023;22(4):343\u20139.","journal-title":"Expert Opin Drug Saf"},{"key":"3015_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050744","author":"CW Lee","year":"2022","unstructured":"Lee CW, Sa S, Hong M, Kim J, Shim SR, Han HW. Adverse events and safety profile of the COVID-19 vaccines in adolescents: safety monitoring for adverse events using real-world data. Vaccines. 2022. https:\/\/doi.org\/10.3390\/vaccines10050744.","journal-title":"Vaccines"},{"issue":"5","key":"3015_CR27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cmi.2023.12.010","volume":"30","author":"MJ Choi","year":"2024","unstructured":"Choi MJ, Na Y, Hyun HJ, Nham E, Yoon JG, Seong H, et al. Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines: a nationwide cohort study using an emulated target trial approach. Clin Microbiol Infect. 2024;30(5):646\u201352.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"3015_CR28","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/cpt.2828","volume":"113","author":"J Durand","year":"2023","unstructured":"Durand J, Dogn\u00e9 JM, Cohet C, Browne K, Gordillo-Mara\u00f1\u00f3n M, Piccolo L, et al. Safety Monitoring of COVID-19 Vaccines: Perspective from the European Medicines Agency. Clin Pharmacol Ther. 2023;113(6):1223\u201334.","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"3015_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40264-024-01405-9","volume":"47","author":"I Caplanusi","year":"2024","unstructured":"Caplanusi I, Szmigiel A, van der Elst M, Schougaard Christiansen ML, Thirstrup S, Zaccaria C, et al. The role of the European Medicines Agency in the safety monitoring of COVID-19 vaccines and future directions in enhancing vaccine safety globally. Drug Saf. 2024;47(5):405\u201318.","journal-title":"Drug Saf"},{"key":"3015_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1114","volume":"373","author":"A Potteg\u00e5rd","year":"2021","unstructured":"Potteg\u00e5rd A, Lund LC, Karlstad \u00d8, Dahl J, Andersen M, Hallas J, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ. 2021;373: n1114.","journal-title":"BMJ"},{"key":"3015_CR31","volume":"13","author":"NJ Andrews","year":"2022","unstructured":"Andrews NJ, Stowe J, Ramsay ME, Miller E. Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: a national cohort study in England. Lancet Reg Health. 2022;13: 100260.","journal-title":"Lancet Reg Health"},{"issue":"4","key":"3015_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ana.26172","volume":"90","author":"JB Schulz","year":"2021","unstructured":"Schulz JB, Berlit P, Diener HC, Gerloff C, Greinacher A, Klein C, et al. COVID-19 vaccine-associated cerebral venous thrombosis in Germany. Ann Neurol. 2021;90(4):627\u201339.","journal-title":"Ann Neurol"},{"key":"3015_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftad010","author":"M Sadat Larijani","year":"2023","unstructured":"Sadat Larijani M, Sorouri R, Eybpoosh S, Doroud D, Moradi L, Ahmadinezhad M, et al. Assessment of long-term adverse events regarding different COVID-19 vaccine regimens within an 18-month follow-up study. Pathog Dis. 2023. https:\/\/doi.org\/10.1093\/femspd\/ftad010.","journal-title":"Pathog Dis"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03015-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03015-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03015-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:39:20Z","timestamp":1757432360000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03015-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3015"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03015-2","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Shahroud University of Medical Sciences, Shahroud, Iran with the reference number of IR.SHMU.REC.1400.012 and IR.SHMU.REC.1400.196. Participation in this study was entirely voluntary, and after explaining the study objectives and methods, a written consent form was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"764"}}